ImmunoPrecise Antibodies Ltd (IPA)
0.3975
+0.05
(+14.09%)
USD |
NASDAQ |
Nov 22, 16:00
0.393
0.00 (0.00%)
After-Hours: 18:38
ImmunoPrecise Antibodies Max Drawdown (5Y): 97.45% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 97.45% |
| September 30, 2024 | 97.10% |
| August 31, 2024 | 96.82% |
| July 31, 2024 | 95.78% |
| June 30, 2024 | 94.74% |
| May 31, 2024 | 94.12% |
| April 30, 2024 | 94.06% |
| March 31, 2024 | 94.06% |
| February 29, 2024 | 94.06% |
| January 31, 2024 | 94.06% |
| December 31, 2023 | 94.06% |
| November 30, 2023 | 93.90% |
| October 31, 2023 | 93.90% |
| September 30, 2023 | 90.59% |
| August 31, 2023 | 90.21% |
| July 31, 2023 | 87.06% |
| June 30, 2023 | 87.06% |
| May 31, 2023 | 87.06% |
| April 30, 2023 | 87.06% |
| March 31, 2023 | 85.19% |
| February 28, 2023 | 80.53% |
| January 31, 2023 | 80.53% |
| December 31, 2022 | 80.53% |
| November 30, 2022 | 80.53% |
| October 31, 2022 | 80.53% |
| Date | Value |
|---|---|
| September 30, 2022 | 80.53% |
| August 31, 2022 | 80.53% |
| July 31, 2022 | 80.53% |
| June 30, 2022 | 80.53% |
| May 31, 2022 | 80.53% |
| April 30, 2022 | 80.53% |
| March 31, 2022 | 80.53% |
| February 28, 2022 | 75.03% |
| January 31, 2022 | 75.00% |
| December 31, 2021 | 75.00% |
| November 30, 2021 | 75.00% |
| October 31, 2021 | 75.00% |
| September 30, 2021 | 75.00% |
| August 31, 2021 | 75.00% |
| July 31, 2021 | 75.00% |
| June 30, 2021 | 75.00% |
| May 31, 2021 | 75.00% |
| April 30, 2021 | 75.00% |
| March 31, 2021 | 75.00% |
| February 28, 2021 | 75.00% |
| January 31, 2021 | 75.00% |
| December 31, 2020 | 75.00% |
| November 30, 2020 | 75.00% |
| October 31, 2020 | 75.00% |
| September 30, 2020 | 75.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
74.76%
Minimum
Nov 2019
97.45%
Maximum
Oct 2024
81.90%
Average
80.53%
Median
Mar 2022
Max Drawdown (5Y) Benchmarks
| Aurinia Pharmaceuticals Inc | 87.58% |
| Edesa Biotech Inc | 99.58% |
| Lexaria Bioscience Corp | 99.02% |
| Xenon Pharmaceuticals Inc | 61.96% |
| ESSA Pharma Inc | 98.68% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -32.36 |
| Beta (5Y) | 0.2779 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 95.61% |
| Historical Sharpe Ratio (5Y) | -0.3009 |
| Historical Sortino (5Y) | -0.8647 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.46% |